

25 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/25/3194042/0/en/Allegro-and-American-Regent-sign-exclusive-licensing-deal-for-SynoglideTM-a-novel-osteoarthritis-treatment-in-animal-health-valued-at-up-to-35-million.html

07 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/07/3162232/0/en/Allegro-showcases-superior-shock-absorbing-capacity-of-injectable-hydrogel-for-osteoarthritis-at-CellMech.html

16 Apr 2025
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-16-2025-39741.pdf

11 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/11/3060129/0/en/Allegro-demonstrates-safety-profile-of-osteoarthritis-hydrogel-in-data-presentation-at-World-Congress-on-Osteoporosis.html

25 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/25/3048441/0/en/Allegro-s-injectable-osteoarthritis-treatment-generates-positive-safety-results-in-preclinical-studies.html

04 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2025/03/04/3036183/0/en/Allegro-reports-positive-safety-data-for-its-injectable-osteoarthritis-treatment-in-three-preclinical-studies.html